CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, vol.23, no.4, pp.611-621, 2014 (SCI-Expanded)
Background: Prior studies suggested that glycans were differentially expressed in patients with ovarian cancer and controls. Wehypothesized that glycan-based biomarkers might serve as a diagnostic test for ovarian cancer and evaluated the ability of glycans to distinguish ovarian cancer cases from matched controls.